https://www.wsj.com/articles/they-developed-their-coronavirus-vaccine-in-salks-shadow-11586557454?mod=opinion_lead_pos7
Pittsburgh
Jonas Salk developed the polio vaccine at a University of Pittsburgh lab. The deadly disease that crippled infants disappeared almost overnight, and Salk became a hero. He wasn’t Steel City’s only history-making physician. Thomas Starzl, who performed the first liver transplant in 1963, joined the Pitt faculty in 1981.
As the world faces another terrifying disease, Pitt medical scientists are again at work on a potentially revolutionary vaccine. Louis Falo and Andrea Gambotto, respectively a dermatologist and a surgeon, have developed a Covid-19 inoculation that rapidly produces large numbers of coronavirus antibodies when injected in mice. A peer-reviewed paper describing their work appeared in the journal EBioMedicine, which is published by The Lancet. They await approval from the Food and Drug Administration to conduct human trials on their vaccine candidate, which is delivered via a unique skin patch containing 400 tiny needles.
“This is a collision of two stories,” Dr. Falo says. “We’ve been developing the delivery technologies for this for the past several years and working with Dr. Gambotto in trying to use the skin as the ideal target for vaccine delivery. While we were doing that, Dr. Gambotto has been working on SARS and MERS.” The two physicians’ labs are next door to each other.